"St. Mary Medical Center is a recipient of the America's 100 Best Hospitals award for three consecutive years, St. Mary offers advanced non-invasive treatments, adult and pediatric emergency services, inpatient medical and rehabilitation facilities, along with supportive health and wellness classes."

During the past decade, St. Mary Medical Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 14 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Mary Medical Center" #1 sponsor was "Bristol-Myers Squibb" with 6 trials, followed by "Abbott Medical Devices" with 4 trials sponsored, "Agendia" with 4 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored and "Alexion" with 4 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Mary Medical Center" #1 collaborator was "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator, "Amylin Pharmaceuticals, LLC." with 1 trials as a collaborator, "Boston Medical Center" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Cardialysis BV" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "St. Mary Medical Center" are "Breast Cancer" (4 trials), "Coronary Artery Disease" (4 trials), "Coronary Stenosis" (2 trials), "Breast Neoplasms" (1 trials) and "Breast Tumor" (1 trials). Many other conditions were trialed in "St. Mary Medical Center" in a lesser frequency.

Most popular intervention types in "St. Mary Medical Center" are "Drug" (19 trials), "Device" (12 trials), "Biological" (3 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (5 trials), "Carboplatin" (3 trials), "Docetaxel" (3 trials), "Ipilimumab" (3 trials) and "Gemcitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "St. Mary Medical Center" are 29 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "St. Mary Medical Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in St. Mary Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in St. Mary Medical Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".

St. Mary Medical Center has several departments that took part in Clinical trials: "St. Mary Regional Cancer Center" - 17 trials, "Saint Mary Regional Center" - 7 trials